We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-15.62%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$163B
AUM Growth
+$35.8B
Cap. Flow
+$63.1B
Cap. Flow %
38.57%
Top 10 Hldgs %
39.01%
Holding
5,544
New
560
Increased
1,332
Reduced
2,502
Closed
413

Sector Composition

Rank Sector Weight
1 Technology 12.9%
2 Financials 7.33%
3 Healthcare 6.04%
4 Consumer Discretionary 5.46%
5 Communication Services 3.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTX icon
3601
Minerals Technologies
MTX
$2.34B
$101K ﹤0.01%
1,645
-3,899
-70% -$249K
AIOS
3602
AIOS Tech
AIOS
$39M
$101K ﹤0.01%
805
ROCL
3603
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$101K ﹤0.01%
+10,000
New +$98.8K
BGXX
3604
DELISTED
Bright Green Corporation Common Stock
BGXX
$101K ﹤0.01%
+45,420
New +$310K
BLNG
3605
DELISTED
Belong Acquisition Corp. Class A Common Stock
BLNG
$101K ﹤0.01%
10,299
+1,799
+21% +$17.6K
BIOR
3606
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$101K ﹤0.01%
580
AVXL icon
3607
Anavex Life Sciences
AVXL
$310M
$100K ﹤0.01%
10,000
-109,911
-92% -$1.04M
BNO icon
3608
United States Brent Oil Fund
BNO
$727M
$100K ﹤0.01%
+3,040
New +$97.7K
CGC
3609
PUT
Canopy Growth
CGC
$410M
$100K ﹤0.01%
3,520
GSBC icon
3610
Great Southern Bancorp
GSBC
$878M
$100K ﹤0.01%
1,711
-8,863
-84% -$516K
ACIC icon
3611
American Coastal Insurance
ACIC
$494M
$99K ﹤0.01%
63,768
-3,302
-5% -$7.01K
CBZ icon
3612
CBIZ
CBZ
$2.96B
$99K ﹤0.01%
2,466
-5,710
-70% -$231K
EHTH icon
3613
eHealth
EHTH
$43.9M
$99K ﹤0.01%
10,684
-8,502
-44% -$86.5K
HAPN
3614
Happen Inc
HAPN
$2.24B
$99K ﹤0.01%
8,500
-12,938
-60% -$182K
LYTS icon
3615
LSI Industries
LYTS
$924M
$99K ﹤0.01%
16,001
UTI icon
3616
Universal Technical Institute
UTI
$1.59B
$99K ﹤0.01%
13,827
+1,580
+13% +$13.9K
UWMC icon
3617
UWM Holdings
UWMC
$434M
$99K ﹤0.01%
28,021
-4,602
-14% -$17.6K
FOCS
3618
DELISTED
Focus Financial Partners Inc. Class A
FOCS
$99K ﹤0.01%
2,911
-9,609
-77% -$367K
AUR icon
3619
Aurora
AUR
$13.8B
$98K ﹤0.01%
51,303
+11,646
+29% +$42.9K
MCY icon
3620
Mercury Insurance
MCY
$6.07B
$98K ﹤0.01%
2,213
-6,448
-74% -$319K
ORGO icon
3621
Organogenesis Holdings
ORGO
$239M
$98K ﹤0.01%
20,040
-32,041
-62% -$197K
SLQT icon
3622
SelectQuote
SLQT
$121M
$98K ﹤0.01%
39,349
-61,530
-61% -$158K
ZNTL icon
3623
Zentalis Pharmaceuticals
ZNTL
$300M
$97K ﹤0.01%
3,445
-3,409
-50% -$90.3K
STKL
3624
DELISTED
SunOpta
STKL
$96K ﹤0.01%
+12,356
New +$81.4K
APEI icon
3625
American Public Education
APEI
$940M
$95K ﹤0.01%
5,866
-9,081
-61% -$155K

Similar funds

Barclays's Q2 2022 Portfolio in Review

As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.

  • Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
  • Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
  • Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
  • Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
  • Barclays opened 560 new positions and closed 413 in Q2 2022.
  • Barclays's portfolio value rose 28% quarter-over-quarter to $163B.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.